Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine in Liver Transplant
NCT04376281Completed
- Sponsor
- Cairo University
- Start
- Dec 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of norepinephrine in Liver cirrhosis (LC), sponsored by Cairo University. Primary endpoint: Change in Cardiac Output. Started Dec 2019; status: completed.
02
Drugs
norepinephrine
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT04376281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04376281.